Psychiatry and Neurology, Neurology · Armonk, NY
NPI
1700249919
Since 2016
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
99 Business Park Dr
Armonk, NY, 10504
Phone (914) 849-7900
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
183 services
Medicare patients, 2024
141
Average age 70
Drug cost, 2024
$2.1M
1,183 prescriptions
Company payments, 2025
$18K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samantha E Epstein was code 99214 (office e&m - established), 70 times for 65 patients. In total Samantha E Epstein billed 183 services in 11 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 70 | 65 | $85.81 | $6,007 |
| 99205 Office E&M - New | Office | 51 | 51 | $195.91 | $9,991 |
| 99215 Office E&M - Established | Office | 27 | 26 | $125.77 | $3,396 |
By year: 2022 $5,965 for 65 services; 2023 $30K for 307 services; 2024 $22K for 183 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samantha E Epstein prescribed most often to Medicare patients was Gabapentin, with 152 prescriptions and refills. In total Samantha E Epstein wrote 1,183 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 152 | 233 | 47 | $2,084 |
| Dalfampridine Er Dalfampridine | 126 | 160 | 23 | $20K |
| Baclofen Generic | 104 | 166 | 36 | $2,830 |
| Teriflunomide Generic | 65 | 65 | Under 11 | $47K |
| Vumerity Diroximel Fumarate | 64 | 72 | Under 11 | $597K |
| Kesimpta Pen Ofatumumab | 53 | 53 | Under 11 | $537K |
| Duloxetine Hcl Generic | 42 | 86 | 12 | $1,165 |
| Glatiramer Acetate Generic | 25 | 29 | Under 11 | $44K |
| Emgality Pen Galcanezumab-Gnlm | 25 | 25 | Under 11 | $18K |
| Alprazolam Generic | 24 | 24 | Under 11 | $483 |
| Copaxone Glatiramer Acetate | 23 | 23 | Under 11 | $140K |
| Pregabalin Generic | 23 | 27 | Under 11 | $346 |
| Fingolimod Fingolimod Hcl | 21 | 27 | Under 11 | $6,410 |
| Tizanidine Hcl Generic | 19 | 33 | Under 11 | $308 |
| Omeprazole Generic | 16 | 22 | Under 11 | $196 |
Brand drugs: - claims; generic drugs: 941 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samantha E Epstein $18K ($18K in general payments such as food, travel and fees) from 5 companies. The largest payer was Biogen, Inc. with $18K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.